Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
NuShares Short-Term REIT ETF (NURE) and SPDR Dow Jones REIT ETF (RWR) belong to the same industry segment: US Real Estate. Both ETFs have the same top 3 sector exposures: and Real Estate. NURE is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.25% for RWR. NURE is up 2.55% year-to-date (YTD) with - in YTD flows. RWR performs better with 7.01% YTD performance, and -$140M in YTD flows. Run a side-by-side ETF comparison of NURE and RWR below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | NURE RWR | -2.43%-0.69% | +5.22%+7.19% | +2.55%+7.01% | -5.69%+9.97% | +12.07%+34.80% | +14.66%+33.99% |
| Flows | NURE RWR | --$44M | --$113M | --$140M | -$15M-$224M | -$26M-$40M | +$24M+$111M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | NURE RWR | +15.98%+12.21% | +19.61%+17.05% | +18.15%+17.44% | +19.79%+19.08% |
| Max drawdown | NURE RWR | -4.44%-3.67% | -15.06%-13.37% | -21.13%-18.77% | -35.93%-32.62% |
| Max drawdown duration | NURE RWR | 21d17d | 365d110d | 533d434d | 1420d1499d |
NURE | RWR | |
Last sale 3/12/2026 at 1:37 PM | $28.29 | $104.47 |
| Previous close 03/11/2026 | $28.49 | $105.10 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
NURE | RWR | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
NURE | RWR | |
|---|---|---|
| Last price | $28.29 | $104.47 |
| 1D performance | -0.72% | -0.60% |
| AuM | $31.80 M | $1.68 B |
| E/R | 0.35% | 0.25% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
